Galderma to acquire Alastin Skincare
Galderma has signed a definitive agreement to acquire Alastin Skincare Inc., the company announced in a press release.
Alastin Skincare is a specialty aesthetics company that develops physician-dispensed products that include its patented TriHex Technology.
“Galderma’s business consistently delivers strong results and remains at the forefront of this rapidly expanding market, driven by increasing consumer interest and acceptance of aesthetic procedures. The addition of Alastin, with its synergistic portfolio and expertise in science-proven skincare, increases our ability to serve the needs of consumers and underscores our commitment to be the partner of choice for aesthetic professionals,” Galderma CEO Flemming Ørnskov, MD, MPH, said in the release. “This transaction will further enhance our premium product offering and provides a tremendous platform for future growth. We look forward to welcoming the Alastin team into Galderma and partnering with them to advance the science of dermatology together.”
Alastin Skincare was the fastest growing skincare company in the United States in 2020, with a compound annual growth rate of 106% between 2016 and 2020.